UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uptake and outcomes of robotic gynaecological surgery in England (2006–2018): an account of Hospital Episodes Statistics (HES)

Journal of robotic surgery, 2022-02, Vol.16 (1), p.81-88

2022

Volltextzugriff (PDF)

A step‐wise approach to developing indicators to compare the performance of maternity units using hospital administrative data

BJOG : an international journal of obstetrics and gynaecology, 2018-06, Vol.125 (7), p.857-865

2018

Volltextzugriff (PDF)

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1427-1434

2006

Volltextzugriff (PDF)

Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate

Journal of pharmaceutical sciences, 2004-06, Vol.93 (6), p.1431-1439

2004

Volltextzugriff (PDF)

Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-α (ISIS 3521/CGP 64128A ) in Patients with Cancer

Clinical cancer research, 1999-11, Vol.5 (11), p.3357-3363

1999

Volltextzugriff (PDF)

Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression

Drug metabolism and disposition, 1997-11, Vol.25 (11), p.1272

1997

Volltextzugriff (PDF)

Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats

The Journal of pharmacology and experimental therapeutics, 2001-03, Vol.296 (3), p.890

2001

Volltextzugriff (PDF)

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

The New England journal of medicine, 2019-08, Vol.381 (6), p.531-542

2019

Volltextzugriff (PDF)

Preclinical Evaluation of the Effects of a Novel Antisense Compound Targeting C-raf Kinase in Mice and Monkeys

Toxicological sciences, 1998-12, Vol.46 (2), p.365-375

1998

Volltextzugriff (PDF)

Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-Ras encapsulated in stealth liposomes

Pharmaceutical research, 1999-08, Vol.16 (8), p.1309-1315

1999

Volltextzugriff (PDF)

Fomivirsen: Clinical pharmacology and potential drug interactions

Clinical pharmacokinetics, 2002, Vol.41 (4), p.255-260

2002

Volltextzugriff (PDF)

Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence

JAMA : the journal of the American Medical Association, 2018-10, Vol.320 (16), p.1659

2018

Volltextzugriff (PDF)

A Phase I Trial of c-Raf Kinase Antisense Oligonucleotide ISIS 5132 Administered as a Continuous Intravenous Infusion in Patients with Advanced Cancer

Clinical cancer research, 2000-05, Vol.6 (5), p.1626

2000

Volltextzugriff (PDF)

A Phase I trial of h‐ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

Cancer, 2001-09, Vol.92 (5), p.1265-1271

2001

Volltextzugriff (PDF)

Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides

Anti-cancer drug design, 1997-07, Vol.12 (5), p.383

1997

Volltextzugriff (PDF)

BIOAVAILABILITY OF INTRANASAL PROMETHAZINE DOSAGE FORMS IN DOGS

Pharmacological research, 1998-07, Vol.38 (1), p.35-39

1998

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice

The Journal of pharmacology and experimental therapeutics, 2001-02, Vol.296 (2), p.388

2001

Volltextzugriff (PDF)

Structure−Activity Relationship Study on a Simple Cationic Peptide Motif for Cellular Delivery of Antisense Peptide Nucleic Acid

Journal of medicinal chemistry, 2005-10, Vol.48 (21), p.6741-6749

2005

Volltextzugriff (PDF)

Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)

The Journal of pharmacology and experimental therapeutics, 1997-09, Vol.282 (3), p.1173

1997

Volltextzugriff (PDF)

Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats

The Journal of pharmacology and experimental therapeutics, 2001-03, Vol.296 (3), p.898

2001

Volltextzugriff (PDF)

Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha‐ras mRNA in mouse and monkey

Journal of pharmaceutical sciences, 2001-02, Vol.90 (2), p.182-193

2001

Volltextzugriff (PDF)

A Nonradioisotope Biomedical Assay for Intact Oligonucleotide and Its Chain-Shortened Metabolites Used for Determination of Exposure and Elimination Half-Life of Antisense Drugs in Tissue

Analytical biochemistry, 1999-10, Vol.274 (2), p.241-248

1999

Volltextzugriff (PDF)

Pharmacokinetics and disposition of WR-1065 in the rhesus monkey

Drug metabolism and disposition, 1990-05, Vol.18 (3), p.281

1990

Volltextzugriff (PDF)

The comparative metabolism of diisopropyl methylphosphonate in mink and rats

Archives of environmental contamination and toxicology, 1994-10, Vol.27 (3), p.420-425

1994

Volltextzugriff (PDF)

Characterization of WR-1065 absorption in the rat small intestine

Biopharmaceutics & drug disposition, 1991-05, Vol.12 (4), p.275-284

1991

Volltextzugriff (PDF)

1 – 25 von 1.580

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.355)
Mit Volltextzugriff
(1.247)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(855)
Life Sciences & Biomedicine
(705)
Humans
(439)
Animals
(328)
Female
(323)
Biological And Medical Sciences
(305)
Male
(299)
Medical Sciences
(202)
Adult
(169)
Physical Sciences
(147)
Middle Aged
(124)
Fundamental And Applied Biological Sciences. Psychology
(116)
Pregnancy
(92)
Aged
(82)
Rats
(80)
Mice
(73)
Social Sciences
(72)
Surgery
(68)
Pharmacology. Drug Treatments
(67)
Adolescent
(61)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Uptake and outcomes of robotic gynaecological surgery in England (2006–2018): an account of Hospital Episodes Statistics (HES)

A step‐wise approach to developing indicators to compare the performance of maternity units using hospital administrative data

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate

Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-α (ISIS 3521/CGP 64128A ) in Patients with Cancer

Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression

Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

Preclinical Evaluation of the Effects of a Novel Antisense Compound Targeting C-raf Kinase in Mice and Monkeys

Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-Ras encapsulated in stealth liposomes

Fomivirsen: Clinical pharmacology and potential drug interactions

Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence

A Phase I Trial of c-Raf Kinase Antisense Oligonucleotide ISIS 5132 Administered as a Continuous Intravenous Infusion in Patients with Advanced Cancer

A Phase I trial of h‐ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides

BIOAVAILABILITY OF INTRANASAL PROMETHAZINE DOSAGE FORMS IN DOGS

Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice

Structure−Activity Relationship Study on a Simple Cationic Peptide Motif for Cellular Delivery of Antisense Peptide Nucleic Acid

Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)

Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats

Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha‐ras mRNA in mouse and monkey

A Nonradioisotope Biomedical Assay for Intact Oligonucleotide and Its Chain-Shortened Metabolites Used for Determination of Exposure and Elimination Half-Life of Antisense Drugs in Tissue

Pharmacokinetics and disposition of WR-1065 in the rhesus monkey

The comparative metabolism of diisopropyl methylphosphonate in mink and rats

Characterization of WR-1065 absorption in the rat small intestine

Suchergebnisse filtern